Enrollment is open for participants in a nationwide National Institutes of Health (NIH)-funded clinical trial testing a noninvasive device designed to help alleviate symptoms of carpal tunnel syndrome (CTS).
People diagnosed with carpal tunnel syndrome in the past 12 months and have had the diagnosis confirmed via a nerve conduction study may be eligible to join the study.
The study, which will be conducted remotely, requires that participants wear the study device on the wrist daily for 2 months, followed by 3 months of online follow-up. Participants will also be required to fill out a daily usage log and complete periodic online surveys to evaluate changes in CTS symptoms.
Physical therapists (PTs), physical therapist assistants (PTAs), students, and supporters of the profession shouldn’t wait until National Physical Therapy Month in October to spread the word about the importance of mobility and physical activity—September is Go4Life month, a National Institutes of Health (NIH)-sponsored campaign that provides plenty of opportunities to educate the public on the ways older Americans can stay healthy through maintaining or increasing endurance, strength, balance, and flexibility.
Strongly supported by APTA, Go4Life is an ongoing effort to connect the public and health care providers with information and resources related to healthy aging. In addition to information on how exercise improves health, the Go4Life website includes suggested exercises, workout videos, fitness tracking resources, and access to printed materials including infographics, posters, bookmarks, and postcards, all available for free. The program also offers a free “Speaker’s Toolkit” to help providers develop presentations to target audiences—available by emailing Go4Life@mail.nih.gov.
A revised National Institutes of Health (NIH) rehabilitation research plan made headlines when it was unveiled last fall, and now several journals, including Physical Therapy (PTJ), are helping to shed even more light on where it came from and where it’s going.
This month, the American Journal of Physical Medicine and Rehabilitation published 2 articles on the NIH plan, which creates a roadmap for more cohesive, targeted research on restoring function. The articles—one a recap of a conference discussion on how research areas should be prioritized, and the other a summary of the overall research action plan—help to provide context for that core document. In April, PTJ will publish the same articles, accompanied by an editorial from Editor in Chief Alan Jette, PT, PhD, FAPTA, who was a member of the blue ribbon panel that created the initial recommendations for the plan.
Rehabilitation research, one of APTA’s longstanding areas of advocacy, has just received a major boost with the publication of a revised National Institutes of Health (NIH) Rehabilitation Research Plan, a 5-year roadmap intended to address a broad swath of research science. Nearly 2 years in development, the revision is the first change to the plan made in over 2 decades, and was guided by a blue ribbon panel that included prominent APTA members and physical therapy researchers.
The plan, which will guide NIH support for rehabilitation medicine, addresses 6 priority areas: the need for rehabilitation research, NIH’s investment in rehabilitation research, current rehab research activities at NIH, coordination with other federal agencies, and opportunities, needs, and priorities. According to NIH, each area has witnessed significant change since the 1993 edition of the plan, attributable to everything from an increase in rehabilitation researchers and growth in evidence to advances in brain-computer interfaces and other technologies that have altered the rehabilitation landscape.
Could brain damage poststroke be reversed? Researchers in a National Institutes of Health (NIH)-funded study say they have found a combination of human stem cells and a protein that created new, functional neurons in the brains of stroke-induced mice.
In the August 22 edition of Nature Medicine, researchers from the University of Southern California outline how they combined 2 methods that individually have demonstrated limited success as treatments for neurologic injury poststroke: surgical grafting of human neural stem cells in the damaged area and administration of the 3KL3A-APC protein, which is derived from the human-activated protein-C.
APTA’s efforts to support improvements in rehabilitation research just received a major boost by way of a US Senate Committee, which has completed the “markup” phase of a bill that would bolster research efforts at the National Institutes of Health (NIH).
Next stop: the Senate floor.
Titled the “Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act,” (S. 800), the bill passed through markup by the Senate Committee on Health, Education, Labor, and Pensions (HELP) with only minor changes. The Disability Rehabilitation and Research Coalition (DRRC) worked with NIH and the office of Sen Mark Kirk (R-IL), the bill’s sponsor, to develop the necessary compromises. APTA is on the steering committee of DRRC, which is composed of over 40 organizations committed to promoting rehabilitation research.
Nearly 1 in 3 reproductive-aged women may be experiencing chronic or cyclic pelvic pain, with many cases going unreported and untreated, according to a new report from the National Institutes of Health (NIH).
In a study designed to assess the connection between pelvic pain and endometriosis, researchers from NIH and the University of Utah School of Medicine surveyed 473 18- to 44-year-old women scheduled to undergo surgery or imaging. The reasons for the surgery or imaging included infertility, menstrual irregularities, tubal sterilization, masses or lumps in the pelvic region, or pelvic pain.
Prior to surgery, the women answered questions about the location and severity of any pain they had experienced in the past 6 months. The survey included questions about 17 specific types of pain related to sexual intercourse, menstrual period, urination or bowel elimination, or other pain, such as muscle or joint pain or migraine headaches.